Huile essentielle de Genévrier Commun
Food supplement declared in France, declaration No 2020-11-1029
Huile essentielle de Genévrier Commun (HALOMA) is a food supplement declared in France. Status: withdrawal from the market announced for 2 July 2028. Main ingredients: Juniperus communis 74 mg per day. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- HALOMA
- Food business operator placing the product on the market
- LA SERRE
- Status
- Withdrawal from the market announced for 2 July 2028
- Form
- Dropper
- Daily dose
- 74 mg
- Directions for use
- Prendre au maximum 1 goutte, 2 fois par jour
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Kidney failure, Infants (under 1 year), Prolonged use
Declaration 171336, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Juniperus communis L. | Essence (fruit) | Distillation | 74 mg |
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne pas utiliser pure, ni diluée dans de l’eau. Ne pas dépasser la dose journalière recommandée. Ce produit ne peut en aucun cas remplacer une alimentation équilibrée et variée ainsi qu'un mode de vie sain. Il est recommandé de suivre les conseils d’utilisation d’un professionnel de santé avant d’utiliser les huiles essentielles. Réservé à l'adulte. Ne pas utiliser sans avis médical chez les femmes enceintes ou allaitant, les personnes ayant des antécédents de troubles convulsifs ou épileptiques, les personnes âgées, les personnes allergiques ou sensibles aux huiles essentielles. Déconseillé en cas d'insuffisance rénale. Ne pas dépasser 6 semaines de prise. Tenir hors déportée des enfants. Conserver le flacon bien fermé dans un endroit frais et à l'abri de la lumière.
Regulatory points
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Withdrawal from the market announced for 2 July 2028, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Juniperus communis L.
Read the warning, when it applies and the studies cited
Juniper - Juniperus Communis
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Mills et al. 2006).
Sources cited by Health Canada (1)
- Mills E, Dugoua J, Perri D, Koren G. Herbal Medicines in Pregnancy and Lactation: An Evidence-Based Approach. London (UK): Taylor and Francis Medical; 2006.
Contraindications
Do not use if you are pregnant (Brinker 2010; Bradley 2006; ESCOP 2003; Hoffmann 2003).
Sources cited by Health Canada (4)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
Do not use if you have a kidney disorder (Brinker 2010; Bradley 2006; ESCOP 2003; Hoffmann 2003).
Sources cited by Health Canada (4)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Huile essentielle de genévrier commun La Vie Claire, declared in 2022 : same declared composition
- Huile essentielle de Genévrier commun PRANAROM, declared in 2021 : same declared composition
Brand : HALOMA
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Huile essentielle de Genévrier Commun (HALOMA): composition and regulation”, https://compoatlas.com/en/supplements/products/171336-huile-essentielle-de-genevrier-commun, updated 15 November 2026.